Status:
UNKNOWN
Registry Study of Pharmacotherapy and Clinical Outcomes in Elderly Patients With Coronary Heart Disease (PHARM-ageing)
Lead Sponsor:
Beijing Anzhen Hospital
Conditions:
Elderly Patients
Coronary Heart Disease
Eligibility:
All Genders
65+ years
Brief Summary
A registry study on drug therapy and clinical outcomes in elderly patients with coronary heart disease
Eligibility Criteria
Inclusion
- Informed consent has been signed
- Patients diagnosed in our hospital with coronary heart disease
- Age ≥65 years
Exclusion
- Severe lack of important information such as history of previous medication, history of previous disease, history of surgery.
- Mental disorders, or inability to communicate effectively with researchers, or failure to comply with research protocols.
Key Trial Info
Start Date :
February 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
15000 Patients enrolled
Trial Details
Trial ID
NCT05246722
Start Date
February 1 2022
End Date
December 1 2025
Last Update
February 18 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.